world
Royan Institute findings highlight MSCs’ potential for cell-based ASD therapy
Tehran Times
September 22, 2026
via Tehran TimesYou're reading one story from Newsaly
Newsaly brings together 60,000+ newspaper articles, 30,000+ podcasts and 10,000+ magazine articles from around the world.
A World Of News, One Window.
Explore Today's News
TEHRAN – Researchers from Royan Institute, in a study, have managed to lower the Childhood Autism Rating Scale (CARS) scores and certain inflammatory biomarkers in children with autism spectrum disorder (ASD) using allogeneic mesenchymal stromal cells (MSCs) derived from umbilical cord Wharton’s jel
Read the full story
Explore More On Newsaly
Voices (0)
Share a 15-second voice reaction. Voices automatically disappear after 10 days.
Sign in to record a voice on this article.
Be the first to share a voice on this article.